SCHEMBL4074110

SCHEMBL4074110

Fc1cc(F)cc(N2CC[CH]CC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.40
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
GFER P55789 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPY5R Q15761 3/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
HTR1A P08908 2/20 0.32
FFAR4 Q5NUL3 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
TTR P02766 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065775 0.86 MAOB (0.38) MAOBALOX5
SCHEMBL30082481 0.80 MAOB (0.42) MAOBALOX5ALDH1A1LMNAMAPT
SCHEMBL9831211 0.80 ALDH1A1 (0.44) MAOBALOX5ALDH1A1LMNAMAPT
SCHEMBL1267656 0.79 BPTF (0.49) ALOX5ALDH1A1MAPTHTTHTR1A
SCHEMBL19212343 0.78 NPC1 (0.46) MAOBALDH1A1LMNAMAPTMAPK1
SCHEMBL1266996 0.76 MAPT (0.59) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL3045513 0.74 ADRB1 (0.57) ALDH1A1LMNAMAPTHTTHTR1A
SCHEMBL3508314 0.74 KDM4E (0.50) ALDH1A1LMNAMAPTMAPK1HTT
SCHEMBL30853515 0.74 LGMN (0.46) MAOBALOX5ALDH1A1LMNAMAPT
SCHEMBL19248969 0.74 NPC1 (0.49) MAOBALDH1A1LMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed
US-20040259890-A1 Spiro compounds MSD K.K. (JP) 2004-12-23 US disclosed
EP-1415986-A1 SPIRO COMPOUNDS BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259890-A1 Spiro compounds OPRD1, PER2, OPRK1 MAOB 571/4885ALOX5 1616/4885ALDH1A1 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.